In situ Reconstruction of Humoral Immune Response Against Sperm: Comparison of SCID and NOD/SCID Mouse Models

被引:2
|
作者
Grygielska, Beata [1 ]
Kamieniczna, Marzena [1 ]
Wiland, Ewa [1 ]
Kurpisz, Maciej [1 ]
机构
[1] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland
关键词
Antisperm antibodies; in situ sensitization; NOD-SCID mice; SCID mice; MONOCLONAL-ANTIBODIES; CELLS; VIVO; IDENTIFICATION; SYSTEM;
D O I
10.1111/j.1600-0897.2008.00675.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Comparison of two types of immunocompromised mouse strains (SCID and NOD/SCID) for production of human antisperm antibodies (AsA). Human peripheral blood lymphocytes (PBL) were grafted to mouse peritoneal cavity and sensitized with natively glycosylated and N-deglycosylated sperm extracts. NOD/SCID mice inoculated with hu-PBLs exhibited higher AsA titres with a tendency for greater sperm agglutination than human AsA raised in SCID mouse model. A comparison between 'native' and deglycosylated sperm extracts revealed higher agglutination titres by sera induced with the latter ones. Inhibitory effect of human polyclonal AsA in sperm penetration assay, however, produced opposite results to that for agglutination. Western immunoblotting was used to evaluate reactive sperm antigens prior to and after in situ sensitization showing multiple bands different from positive reactions brought by original sera of in vivo primed AsA-positive males. It seems that in situ generated AsA recognized sperm entities different from those revealed by blood donor's sera samples.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 50 条
  • [31] Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia
    Bougie, Daniel W.
    Nayak, Dhirendra
    Boylan, Brian
    Newman, Peter J.
    Aster, Richard H.
    BLOOD, 2010, 116 (16) : 3033 - 3038
  • [32] The development of DNA vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models
    Okada, M
    Takemoto, Y
    Okuno, Y
    Hashimoto, S
    Fukunaga, Y
    Tanaka, T
    Kita, Y
    Kuwayama, S
    Muraki, Y
    Kanamaru, N
    Takai, H
    Okada, C
    Sakaguchi, Y
    Furukawa, I
    Yamada, K
    Izumiya, M
    Yoshida, S
    Matsumoto, M
    Kase, T
    Peiris, M
    Ishida, I
    Morikawa, S
    Tashiro, M
    Sakatani, M
    FASEB JOURNAL, 2005, 19 (04): : A895 - A895
  • [33] Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
    Okada, Masaji
    Okuno, Yoshinobu
    Hashimoto, Satomi
    Kita, Yoko
    Kanamaru, Noriko
    Nishida, Yasuko
    Tsunai, Yoshie
    Inoue, Ruriko
    Nakatani, Hitoshi
    Fukamizu, Reiko
    Namie, Yumi
    Yamada, Junko
    Takao, Kyoko
    Asai, Ritsuko
    Asaki, Ryoko
    Kase, Tetsuo
    Takemoto, Yuji
    Yoshida, Shigeto
    Peiris, J. S. M.
    Chen, Pei-Jer
    Yamamoto, Naoki
    Nomura, Tatsuji
    Ishida, Isao
    Morikawa, Shigeru
    Tashiro, Masato
    Sakatani, Mitsunori
    VACCINE, 2007, 25 (16) : 3038 - 3040
  • [34] MOSQUITO SALIVA PROMOTES A TH1 IMMUNE RESPONSE IN HUMANIZED NOD-SCID IL2RGAMMA-NULL MICE
    Peterson, Kassandra L.
    Vogt, Megan
    Hernandez-Sanabria, Mayra
    Mondragon, Enid
    Lahon, Anismrita
    Arya, Ravi
    Paust, Silke
    Rico-Hesse, Rebecca
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 222 - 222
  • [35] Lin- reselection over time results in stable repopulating potency in dose response assays using the NOD/Scid mouse model.
    Kraus, M
    Wilder, P
    Stevens, Z
    Massengill, J
    Rider, K
    Vanosdol, P
    BLOOD, 2001, 98 (11) : 659A - 660A
  • [36] Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model
    Alfonzo, M
    Blanc, D
    Troadec, C
    Huerre, M
    Eliaszewicz, M
    Gónzalez, G
    Koyanagi, Y
    Scott-Algara, D
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 129 (03): : 411 - 419
  • [37] Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia
    H Graf Einsiedel
    L Kawan
    C Eckert
    O Witt
    I Fichtner
    G Henze
    K Seeger
    Leukemia, 2006, 20 : 1435 - 1436
  • [38] Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia
    Einsiedel, H. Graf
    Kawan, L.
    Eckert, C.
    Witt, O.
    Fichtner, I.
    Henze, G.
    Seeger, K.
    LEUKEMIA, 2006, 20 (08) : 1435 - 1436
  • [39] Long-term maintenance of skin immune system in a NOD-Scid IL2rγnull mouse model transplanted with human skin
    Soria, Angele
    Boccara, David
    Chonco, Louis
    Yahia, Nora
    Dufossee, Melody
    Cardinaud, Sylvain
    Moris, Arnaud
    Liard, Christelle
    Joulin-Giet, Alix
    Julithe, Marion
    Mimoun, Maurice
    Combadiere, Behazine
    Perrin, Helene
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (11) : 850 - 852
  • [40] EVIDENCE FOR HUMORAL IMMUNE-RESPONSE TO GAD(65) IN NOD MOUSE BY GENERATION OF GAD(65) MONOCLONAL-ANTIBODIES
    AUGSTEIN, P
    ZIEGLER, B
    SCHLOSSER, M
    HAMANN, J
    HAHMANN, J
    NORTHEMANN, W
    ZIEGLER, M
    DIABETOLOGIA, 1994, 37 : A93 - A93